Creatine Kinase Test

Creatine kinase (CK), also known as creatine phosphokinase (CPK), is an enzyme found in muscle cells and the brain that plays an important role in energy metabolism. It helps store and rapidly regenerate adenosine triphosphate (ATP), the main energy currency of the cell, by converting creatine into phosphocreatine and vice versa. This system acts like a quick-access battery pack, especially in tissues with high and fluctuating energy demands, such as skeletal muscle, heart muscle, and the brain.

CK exists in different forms, or isoenzymes, based on where it’s produced:

• CK-MM comes mostly from skeletal muscle
• CK-MB is more specific to heart muscle
• CK-BB is found in the brain and other smooth tissues

Under normal conditions, small amounts of CK leak into the bloodstream during routine muscle turnover. However, when muscle cells are damaged, large amounts of CK can spill into the blood, causing CK levels to rise. This makes CK a useful biomarker in a wide range of clinical settings.

One of its best-known uses is in the diagnosis of acute myocardial infarction (AMI), a heart attack. CK-MB, the heart-specific isoenzyme, rises about 12 hours after symptoms begin, peaks around 24-36 hours, and returns to normal within 2-3 days. While cardiac troponins have largely replaced CK-MB for diagnosing heart attacks due to better accuracy, CK-MB remains helpful in specific cases, such as detecting a reinfarction or evaluating post-surgical cardiac injury.

CK is also a key marker for rhabdomyolysis, a condition where skeletal muscle breaks down rapidly, releasing proteins like CK and myoglobin into the blood. This can lead to acute kidney injury if not treated promptly with IV fluids. Causes of rhabdomyolysis include trauma, extreme exercise, statin use (especially when combined with certain drugs), infections, and genetic muscle disorders. CK levels in this setting can exceed 1,000 IU/L, with severe cases exceeding 5,000 IU/L or even 70,000 IU/L.

In neuromuscular disorders, especially inherited diseases like Duchenne muscular dystrophy (DMD), CK levels can be chronically elevated long before symptoms appear. The CK-MM test is used in newborn screening programs to help identify boys at risk for DMD early, when interventions may be more effective.

Exercise, especially intense or unfamiliar workouts, can also cause CK to rise. This is more pronounced in people who are untrained or starting new high-intensity routines. Importantly, these rises are usually temporary and not dangerous in otherwise healthy individuals.

Interestingly, CK levels are also linked to metabolic and cardiovascular health. Studies show higher CK activity is associated with increased blood pressure, especially in people of African descent, and may play a role in sodium retention. Elevated CK has also been associated with insulin resistance and higher levels of glycated hemoglobin (HbA1c), a long-term marker of blood sugar control.

On the other end of the spectrum, low CK levels can also be clinically meaningful. People who are bedridden, elderly, or have very low muscle mass may have reduced CK activity. In chronic kidney disease (CKD), low CK levels have been linked to higher mortality risk, suggesting that CK may reflect more than just muscle damage; it may also signal frailty or poor physiological reserve.